{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:29:07Z","timestamp":1777606147112,"version":"3.51.4"},"reference-count":40,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Bone metastasis and steroids are known to activate the coagulation system and induce osteoporosis, pathological bone fractures, and bone pain. Heparanase is a protein known to enhance the hemostatic system and to promote angiogenesis, metastasis, and inflammation. The objective of the present study was to evaluate the effects of steroids and malignancy on the coagulation factors and osteoblast activity in the bone tissue. The effects of dexacort and malignant medium were evaluated in osteoblasts derived from human bone marrow mesenchymal stem cells and human umbilical vein endothelial cells (HUVECs). The bones of mice treated with dexacort for 1 month were studied. Bone biopsies of ten patients with bone metastasis, ten with steroid-induced avascular necrosis (AVN), and ten with osteoarthritis were compared to ten controls. We found that dexacort and malignant medium significantly increased the heparanase levels in osteoblasts and HUVECs and decreased the levels of alkaline phosphatase (ALKP). Peptide 16AC, derived from heparanase, which interacts with tissue factor (TF), further increased the effect, while peptide 6, which inhibits interactions between heparanase and TF, reversed the effect in these cells. The bone microcirculation of mice treated with dexacort exhibited significantly higher levels of heparanase, TF, TF pathway inhibitor (TFPI), TFPI-2, thrombin, and syndecan-1, but reduced levels of osteocalcin and ALKP. The pathological human bone biopsies\u2019 microcirculation exhibited significantly dilated blood vessels and higher levels of heparanase, TF, TFPI, TFPI-2, and fibrin. In summary, steroids and malignancy increased the activation of the coagulation system in the bone microcirculation and reduced the osteoblast activity. Heparanase inhibitors should be further investigated to attenuate bone fractures and pain.<\/jats:p>","DOI":"10.3390\/biom14121506","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T04:02:18Z","timestamp":1732593738000},"page":"1506","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Steroids and Malignancy Increase Local Heparanase and Decrease Markers of Osteoblast Activity in Bone Tissue Microcirculation"],"prefix":"10.3390","volume":"14","author":[{"given":"Keren","family":"Asayag","sequence":"first","affiliation":[{"name":"Thrombosis and Hemostasis Unit, Rambam Health Care Campus, Haifa 3109601, Israel"},{"name":"The Ruth and Bruce Rappaport Faculty of Medicine, Israel Institute of Technology\u2014Technion, Haifa 3109601, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1692-3772","authenticated-orcid":false,"given":"Eli","family":"Peled","sequence":"additional","affiliation":[{"name":"The Ruth and Bruce Rappaport Faculty of Medicine, Israel Institute of Technology\u2014Technion, Haifa 3109601, Israel"},{"name":"Orthopedic Division, Rambam Health Care Campus, Haifa 3109601, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai","family":"Assalia","sequence":"additional","affiliation":[{"name":"Thrombosis and Hemostasis Unit, Rambam Health Care Campus, Haifa 3109601, Israel"},{"name":"The Ruth and Bruce Rappaport Faculty of Medicine, Israel Institute of Technology\u2014Technion, Haifa 3109601, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonatan","family":"Crispel","sequence":"additional","affiliation":[{"name":"Thrombosis and Hemostasis Unit, Rambam Health Care Campus, Haifa 3109601, Israel"},{"name":"The Ruth and Bruce Rappaport Faculty of Medicine, Israel Institute of Technology\u2014Technion, Haifa 3109601, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Yanovich","sequence":"additional","affiliation":[{"name":"Thrombosis and Hemostasis Unit, Rambam Health Care Campus, Haifa 3109601, Israel"},{"name":"The Ruth and Bruce Rappaport Faculty of Medicine, Israel Institute of Technology\u2014Technion, Haifa 3109601, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haim","family":"Cohen","sequence":"additional","affiliation":[{"name":"Thrombosis and Hemostasis Unit, Rambam Health Care Campus, Haifa 3109601, Israel"},{"name":"The Ruth and Bruce Rappaport Faculty of Medicine, Israel Institute of Technology\u2014Technion, Haifa 3109601, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anat","family":"Keren-Politansky","sequence":"additional","affiliation":[{"name":"Thrombosis and Hemostasis Unit, Rambam Health Care Campus, Haifa 3109601, Israel"},{"name":"The Ruth and Bruce Rappaport Faculty of Medicine, Israel Institute of Technology\u2014Technion, Haifa 3109601, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yona","family":"Nadir","sequence":"additional","affiliation":[{"name":"Thrombosis and Hemostasis Unit, Rambam Health Care Campus, Haifa 3109601, Israel"},{"name":"The Ruth and Bruce Rappaport Faculty of Medicine, Israel Institute of Technology\u2014Technion, Haifa 3109601, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,26]]},"reference":[{"key":"ref_1","first-page":"4","article-title":"The physiology of bone blood flow: A review","volume":"88","author":"McCarthy","year":"2006","journal-title":"J. Bone Jt. Surg. Am."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4248\/BR201303001","article-title":"The Key Role of the Blood Supply to Bone","volume":"1","author":"Marenzana","year":"2013","journal-title":"Bone Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.abb.2010.07.020","article-title":"Bone and bone marrow: The same organ","volume":"503","author":"Capannolo","year":"2010","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_4","unstructured":"Feingold, K.R., Anawalt, B., Blackman, M.R., Boyce, A., Chrousos, G., Corpas, E., de Herder, W.W., Dhatariya, K., Dungan, K., and Hofland, J. (2000). An Overview of Glucocorticoid-Induced Osteoporosis. Endotext, MDText.com, Inc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2174\/18715303112129990027","article-title":"Osteoporosis in patients with breast and prostate cancer: Effect of disease and treatment modalities","volume":"13","author":"Legakis","year":"2013","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e0033","DOI":"10.5041\/RMMJ.10349","article-title":"Cancer and Thrombosis-New Insights","volume":"9","author":"Nadir","year":"2018","journal-title":"Rambam Maimonides Med. J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1042\/bj3301341","article-title":"Human platelet heparanase: Purification, characterization and catalytic activity","volume":"330","author":"Freeman","year":"1998","journal-title":"Biochem. J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"18770","DOI":"10.1074\/jbc.273.30.18770","article-title":"Substrate specificity of heparanases from human hepatoma and platelets","volume":"273","author":"Pikas","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1002\/pgr2.6","article-title":"Heparanase\u2014A single protein with multiple enzymatic and nonenzymatic functions","volume":"1","author":"Vlodavsky","year":"2023","journal-title":"Proteoglycan Res."},{"key":"ref_10","first-page":"M99","article-title":"Heparanase: A key enzyme involved in cell invasion","volume":"1471","author":"Parish","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1172\/JCI13662","article-title":"Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis","volume":"108","author":"Vlodavsky","year":"2001","journal-title":"J. Clin. Investig."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/jcp.30995","article-title":"Potential roles of heparanase in cancer therapy: Current trends and future direction","volume":"238","author":"Yang","year":"2023","journal-title":"J. Cell. Physiol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Lebsir, N., Zoulim, F., and Grigorov, B. (2023). Heparanase-1: From Cancer Biology to a Future Antiviral Target. Viruses, 15.","DOI":"10.3390\/v15010237"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1111\/j.1538-7836.2006.02212.x","article-title":"Heparanase induces tissue factor expression in vascular endothelial and cancer cells","volume":"4","author":"Nadir","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.3324\/haematol.2010.023713","article-title":"Heparanase enhances the generation of activated factor X in the presence of tissue factor and activated factor VII","volume":"95","author":"Nadir","year":"2010","journal-title":"Haematologica"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/MBC.0000000000001257","article-title":"The impact of vascular endothelial glycocalyx on the pathogenesis and treatment of disseminated intravascular coagulation","volume":"34","author":"Cao","year":"2023","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1111\/jth.15417","article-title":"Effect of heparanase inhibitor on tissue factor overexpression in platelets and endothelial cells induced by anti-beta2-GPI antibodies","volume":"19","author":"Capozzi","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.thromres.2020.04.039","article-title":"Expression profiles of the internal jugular and saphenous veins: Focus on hemostasis genes","volume":"191","author":"Ziliotto","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/IAE.0000000000002374","article-title":"Increased Systemic Heparanase in Retinal Vein Occlusion Is Associated with Activation of Inflammation and Thrombophilia","volume":"40","author":"Hu","year":"2020","journal-title":"Retina"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1159\/000503085","article-title":"Serum Heparanase Level Is Decreased in Stable Coronary Artery Disease","volume":"28","author":"Gurbuz","year":"2019","journal-title":"Med. Princ. Pract."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1080\/1354750X.2019.1628809","article-title":"Heparanase is a predictive marker for high thrombus burden in patients with ST-segment elevation myocardial infarction","volume":"24","author":"Gurbuz","year":"2019","journal-title":"Biomarkers"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Bohdan, N., Espin, S., Aguila, S., Teruel-Montoya, R., Vicente, V., Corral, J., and Martinez-Martinez, I. (2016). Heparanase Activates Antithrombin through the Binding to Its Heparin Binding Site. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0157834"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1055\/s-0039-1693473","article-title":"Decreasing Tumor Growth and Angiogenesis by Inhibition of Coagulation","volume":"45","author":"Nadir","year":"2019","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1160\/TH13-12-1049","article-title":"Novel peptides that inhibit heparanase activation of the coagulation system","volume":"112","author":"Axelman","year":"2014","journal-title":"Thromb. Haemost."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1111\/jth.13707","article-title":"Involvement of the heparanase procoagulant domain in bleeding and wound healing","volume":"15","author":"Crispel","year":"2017","journal-title":"J. Thromb. Haemost."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"102179","DOI":"10.1016\/j.rpth.2023.102179","article-title":"Tissue factor-heparanase complex: Intracellular nonhemostatic effects","volume":"7","author":"Ghanem","year":"2023","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1242\/jcs.01068","article-title":"Processing and activation of latent heparanase occurs in lysosomes","volume":"117","author":"Zetser","year":"2004","journal-title":"J. Cell. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.bbrc.2006.01.048","article-title":"An ELISA method for the detection and quantification of human heparanase","volume":"341","author":"Shafat","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"8047","DOI":"10.1074\/jbc.M304872200","article-title":"Heparanase degrades syndecan-1 and perlecan heparan sulfate: Functional implications for tumor cell invasion","volume":"279","author":"Reiland","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Huang, X., Reye, G., Momot, K.I., Blick, T., Lloyd, T., Tilley, W.D., Hickey, T.E., Snell, C.E., Okolicsanyi, R.K., and Haupt, L.M. (2020). Heparanase Promotes Syndecan-1 Expression to Mediate Fibrillar Collagen and Mammographic Density in Human Breast Tissue Cultured ex vivo. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.00599"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000093553","article-title":"The impact of heparanese and heparin on cancer metastasis and angiogenesis","volume":"35","author":"Vlodavsky","year":"2006","journal-title":"Pathophysiol. Haemost. Thromb."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.thromres.2012.09.018","article-title":"Heparanase role in the treatment of avascular necrosis of femur head","volume":"131","author":"Peled","year":"2013","journal-title":"Thromb. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/jth.13265","article-title":"The influence of corticosteroids on hemostasis in healthy subjects","volume":"14","author":"Majoor","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1160\/TH16-10-0766","article-title":"Thrombin is a selective inducer of heparanase release from platelets and granulocytes via protease-activated receptor-1","volume":"117","author":"Tatour","year":"2017","journal-title":"Thromb. Haemost."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/jcp.20625","article-title":"Heparanase is expressed in osteoblastic cells and stimulates bone formation and bone mass","volume":"207","author":"Kram","year":"2006","journal-title":"J. Cell. Physiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/JCMA.0000000000000261","article-title":"Topical application of Heparanase-1 facilitates bone remodeling during the healing of bone defects in a mouse model","volume":"83","author":"Chiu","year":"2020","journal-title":"J. Chin. Med. Assoc."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10456-017-9541-1","article-title":"The role of vasculature in bone development, regeneration and proper systemic functioning","volume":"20","author":"Filipowska","year":"2017","journal-title":"Angiogenesis"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.bone.2008.01.007","article-title":"Mobilization of endothelial progenitor cells in fracture healing and distraction osteogenesis","volume":"42","author":"Lee","year":"2008","journal-title":"Bone"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.bone.2011.12.003","article-title":"Mice with increased angiogenesis and osteogenesis due to conditional activation of HIF pathway in osteoblasts are protected from ovariectomy induced bone loss","volume":"50","author":"Zhao","year":"2012","journal-title":"Bone"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1161\/ATVBAHA.109.200154","article-title":"Diabetes mellitus induces bone marrow microangiopathy","volume":"30","author":"Oikawa","year":"2010","journal-title":"Arter. Thromb. Vasc. Biol."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/14\/12\/1506\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:39:28Z","timestamp":1760114368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/14\/12\/1506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,26]]},"references-count":40,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["biom14121506"],"URL":"https:\/\/doi.org\/10.3390\/biom14121506","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,26]]}}}